Skip to main content
. 2019 Jun 15;11(6):3698–3706.

Table 1.

Associations between IL-4 and IL-6 polymorphisms and gastric cancer risk

Genotype Cases, n (%) Controls, n (%) OR (95% CI) AOR (95% CI)a p-value
IL-4 rs2243248
    TT 421 (87.89) 420 (86.96) Reference Reference
    GT 57 (11.90) 62 (12.84) 0.92 (0.63, 1.35) 0.92 (0.63, 1.37) 0.693
    GG 1 (0.21) 1 (0.21) 1.00 (0.06, 16.04) 0.74 (0.05, 12.11) 0.836
    GT/GG 58 (12.11) 63 (13.04) 0.92 (0.63, 1.35) 0.92 (0.63, 1.35) 0.671
    Additive model 0.92 (0.64, 1.34) 0.92 (0.63, 1.34) 0.660
IL-4 rs2070874
    TT 309 (64.51) 321 (66.46) Reference Reference
    TC 147 (30.69) 142 (29.40) 1.08 (0.81, 1.42) 1.03 (0.78, 1.37) 0.817
    CC 23 (4.80) 20 (4.14) 1.19 (0.64, 2.22) 1.24 (0.66, 2.32) 0.511
    TC/CC 170 (35.49) 162 (33.54) 1.09 (0.84, 1.42) 1.06 (0.81, 1.39) 0.685
    Additive model 1.08 (0.87, 1.35) 1.07 (0.85, 1.34) 0.576
IL-4R rs2057768
    TT 125 (26.10) 139 (28.78) Reference Reference
    CT 241 (50.31) 239 (49.48) 1.12 (0.83, 1.51) 1.16 (0.86, 1.58) 0.331
    CC 113 (23.59) 105 (21.74) 1.20 (0.84, 1.71) 1.17 (0.81, 1.69) 0.405
    CT/CC 354 (73.90) 344 (71.22) 1.14 (0.86, 1.52) 1.17 (0.87, 1.56) 0.298
    Additive model 1.10 (0.92, 1.31) 1.09 (0.91, 1.31) 0.349
IL-4R rs2107356
    CC 192 (40.08) 202 (41.82) Reference Reference
    TC 224 (46.76) 215 (44.51) 1.10 (0.84, 1.44) 1.15 (0.87, 1.51) 0.340
    TT 63 (13.15) 66 (13.66) 1.00 (0.68, 1.50) 0.98 (0.65, 1.46) 0.908
    TC/TT 287 (59.92) 281 (58.18) 1.08 (0.83, 1.39) 1.09 (0.84, 1.42) 0.500
    Additive model 1.03 (0.85, 1.24) 1.02 (0.85, 1.23) 0.813
IL-4R rs1805015
    TT 402 (83.92) 404 (83.64) Reference Reference
    CT 76 (15.87) 76 (15.73) 1.01 (0.71, 1.42) 1.00 (0.70, 1.42) 0.994
    CC 1 (0.21) 3 (0.62) 0.34 (0.04, 3.24) 0.34 (0.04, 3.29) 0.351
    CT/CC 77 (16.08) 79 (16.36) 0.98 (0.70, 1.38) 0.97 (0.69, 1.38) 0.880
    Additive model 0.96 (0.69, 1.33) 0.95 (0.68, 1.33) 0.754
IL-4R rs1801275
    AA 326 (68.06) 329 (68.12) Reference Reference
    GA 137 (28.60) 133 (27.54) 1.04 (0.78, 1.38) 1.04 (0.78, 1.38) 0.812
    GG 16 (3.34) 21 (4.35) 0.77 (0.39, 1.50) 0.71 (0.36, 1.41) 0.331
    GA/GG 153 (31.94) 154 (31.88) 1.00 (0.77, 1.32) 0.99 (0.75, 1.30) 0.934
    Additive model 0.97 (0.77, 1.22) 0.95 (0.75, 1.20) 0.662
IL-6 rs6949149
    TT 151 (31.52) 144 (29.81) Reference Reference
    GT 228 (47.60) 248 (51.35) 0.88 (0.66, 1.17) 0.89 (0.66, 1.19) 0.421
    GG 100 (20.88) 91 (18.84) 1.05 (0.73, 1.51) 1.06 (0.73, 1.54) 0.758
    GT/GG 328 (68.48) 339 (70.19) 0.92 (0.70, 1.21) 0.93 (0.70, 1.23) 0.610
    Additive model 1.01 (0.84, 1.21) 1.02 (0.85, 1.22) 0.863
IL-6 rs10499563
    TT 298 (62.21) 303 (62.73) Reference Reference
    TC 163 (34.03) 157 (32.51) 1.06 (0.81, 1.39) 1.08 (0.82, 1.42) 0.602
    CC 18 (3.76) 23 (4.76) 0.80 (0.42, 1.51) 0.84 (0.44, 1.60) 0.601
    TC/CC 181 (37.79) 180 (37.27) 1.02 (0.79, 1.33) 1.05 (0.80, 1.36) 0.747
    Additive model 0.99 (0.79, 1.23) 1.01 (0.81, 1.26) 0.948
IL-6 rs1800796
    CC 226 (47.18) 268 (55.49) Reference Reference
    CG 203 (42.38) 187 (38.72) 1.29 (0.99, 1.68) 1.28 (0.98, 1.68) 0.071
    GG 50 (10.44) 28 (5.80) 2.12 (1.29, 3.48) 2.20 (1.33, 3.63) 0.002
    GC/GG 253 (52.82) 215 (44.51) 1.40 (1.08, 1.80) 1.41 (1.09, 1.82) 0.009
    Additive model 1.38 (1.13, 1.68) 1.39 (1.14, 1.71) 0.001
IL-6R rs2228145
    AA 163 (34.03) 157 (32.51) Reference Reference
    CA 232 (48.43) 235 (48.65) 0.95 (0.72, 1.26) 0.96 (0.72, 1.29) 0.803
    CC 84 (17.54) 91 (18.84) 0.89 (0.62, 1.29) 0.88 (0.61, 1.29) 0.519
    CA/CC 316 (65.97) 326 (67.49) 0.93 (0.71, 1.22) 0.94 (0.72, 1.24) 0.678
    Additive model 0.94 (0.79, 1.13) 0.94 (0.79, 1.13) 0.541
a

Adjusted for age, gender, smoking, drinking, and H. pylori infection status.

p-values <0.05 are shown in bold. AOR, adjusted odds ratio; OR, odds ratio.